Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 30Neoplasm Metastasis 4Advanced Breast Cancer 4Triple Negative Breast Neoplasms 3Polycystic Ovary Syndrome 3Neoplasms 3Endometrial Neoplasms 3Prostatic Neoplasms 2Ovarian Neoplasms 2Infertility 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sexual Dysfunctions, Psychological 1Recurrence 1Pathologic Complete Response 1Neoplasms by Site 1Leiomyoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangiosarcoma 1Head and Neck Neoplasms 1HR+/HER2- Breast Cancer 1HER2 Negative Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Ductal 1Breast Neoplasm Female 1Breast Diseases 1

Interventions

ribociclib 2Specimen Handling 2tucatinib 1trastuzumab biosimilar HLX02 1pertuzumab 1exemestane 1durvalumab 1Trastuzumab 1Taxes 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunoglobulin G 1Genetic Testing 1Fulvestrant 1Drug Therapy 1Doxorubicin 1Docetaxel 1Disulfides 1Cyclophosphamide 1Carboplatin 1Anastrozole 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage II Breast Cancer AJCC v8 × Letrozole × 30 days × Clear all
NCT07391774 2026-05-13

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
1,978 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡